Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 12049957)

Published in Ultrasound Med Biol on April 01, 2002

Authors

Flemming Forsberg1, Adam P Dicker, Mattew L Thakur, Nandkumar M Rawool, Ji-Bin Liu, William T Shi, Levon N Nazarian

Author Affiliations

1: Department of Radiology, Division of Ultrasound, Thomas Jefferson University, Main Building, Suite 763J, 132 South 10th Street, Philadelphia, PA 19107, USA. forsberg@esther.rad.tju.edu

Articles citing this

Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol (2009) 2.27

Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound. Invest Radiol (2012) 1.11

Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy. Eur Radiol (2012) 1.09

Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets (2010) 1.07

Contrast-enhanced ultrasound for molecular imaging of angiogenesis. Eur J Nucl Med Mol Imaging (2010) 0.97

A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals. Mol Imaging Biol (2009) 0.87

Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study. Ultrasonics (2010) 0.86

Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity. Ultrasound Med Biol (2008) 0.82

Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models. Ultrasonics (2013) 0.76

Entropy vs. Energy Waveform Processing: A Comparison Based on the Heat Equation. Entropy (Basel) (2015) 0.75

Molecular imaging metrics to evaluate response to preclinical therapeutic regimens. Front Biosci (Landmark Ed) (2011) 0.75

Articles by these authors

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology (2008) 3.28

Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys (2010) 2.94

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int (2012) 2.86

Accuracy of MRI, MR arthrography, and ultrasound in the diagnosis of rotator cuff tears: a meta-analysis. AJR Am J Roentgenol (2009) 2.40

Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials. J Natl Cancer Inst (2013) 2.35

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol (2010) 2.30

Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res (2003) 2.24

Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Int J Radiat Oncol Biol Phys (2012) 2.12

The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis. Int J Radiat Oncol Biol Phys (2012) 2.10

A hormone-DNA repair circuit governs the response to genotoxic insult. Cancer Discov (2013) 1.97

Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology (2004) 1.95

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lancet Oncol (2007) 1.95

Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. Eur J Cancer (2011) 1.76

Characterization of ultrasound contrast microbubbles using in vitro experiments and viscous and viscoelastic interface models for encapsulation. J Acoust Soc Am (2005) 1.76

Differentiation and definition of vascular-targeted therapies. Clin Cancer Res (2005) 1.74

Improving prognosis of glioblastoma in the 21st century: who has benefited most? Cancer (2011) 1.70

Accuracy of office-based ultrasonography of the shoulder for the diagnosis of rotator cuff tears. J Bone Joint Surg Am (2005) 1.67

Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. Radiology (2004) 1.65

Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov (2012) 1.63

Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int J Cancer (2003) 1.56

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. Int J Radiat Oncol Biol Phys (2012) 1.56

The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle (2011) 1.55

VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma. Int J Radiat Oncol Biol Phys (2007) 1.55

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school. Int J Radiat Oncol Biol Phys (2012) 1.54

Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology (2012) 1.53

Peripheral nerve lesions: role of high-resolution US. Radiographics (2003) 1.52

Sonographically guided percutaneous needle release of the carpal tunnel for treatment of carpal tunnel syndrome: preliminary report. J Ultrasound Med (2012) 1.48

Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy. Urology (2009) 1.45

Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT. Urology (2009) 1.43

Lateral epicondylitis of the elbow: US findings. Radiology (2005) 1.33

Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res (2005) 1.32

Patient-oriented cancer information on the internet: a comparison of wikipedia and a professionally maintained database. J Oncol Pract (2011) 1.31

Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators. Clin Cancer Res (2010) 1.22

Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys (2008) 1.22

Nutrient restriction and radiation therapy for cancer treatment: when less is more. Oncologist (2013) 1.20

Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules. Thyroid (2010) 1.18

Characterization of maxillofacial soft tissue vascular anomalies by ultrasound and color Doppler imaging: an adjuvant to computed tomography and magnetic resonance imaging. J Oral Maxillofac Surg (2003) 1.13

Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers. Int J Radiat Oncol Biol Phys (2005) 1.11

Intrasheath subluxation of the peroneal tendons. J Bone Joint Surg Am (2008) 1.10

Microbubble cavitation imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 1.08

Contrast-enhanced sonographic imaging of lymphatic channels and sentinel lymph nodes. J Ultrasound Med (2005) 1.08

Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J Cell Physiol (2006) 1.07

Real-time ultrasound elastography: its potential role in assessment of breast lesions. Ultrasound Med Biol (2008) 1.07

Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care? Cancer Treat Rev (2012) 1.06

Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology (2002) 1.06

Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncol (2013) 1.05

Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys (2007) 1.04

Inhibition of p73 function by Pifithrin-alpha as revealed by studies in zebrafish embryos. Cell Cycle (2008) 1.03

Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys (2012) 1.02

In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res (2006) 1.02

The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer (2012) 1.01

Sonographically guided percutaneous needle tenotomy for treatment of common extensor tendinosis in the elbow. J Ultrasound Med (2006) 1.01

Musculoskeletal imaging: medicare use, costs, and potential for cost substitution. J Am Coll Radiol (2008) 1.00

Oil-filled polymer microcapsules for ultrasound-mediated delivery of lipophilic drugs. J Control Release (2008) 0.99

In vivo perfusion estimation using subharmonic contrast microbubble signals. J Ultrasound Med (2006) 0.99

In vivo pressure estimation using subharmonic contrast microbubble signals: proof of concept. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 0.99

A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity. Circ Res (2011) 0.98

Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling. Cancer Res (2006) 0.98

High-resolution ultrasonography in the diagnosis and intraoperative management of peripheral nerve lesions. J Neurosurg (2010) 0.98

Material characterization of the encapsulation of an ultrasound contrast microbubble and its subharmonic response: strain-softening interfacial elasticity model. J Acoust Soc Am (2010) 0.97

Current status of sonographically guided radiofrequency ablation techniques. J Ultrasound Med (2007) 0.97

Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids. Nucleic Acids Res (2005) 0.97

Dramatically increased musculoskeletal ultrasound utilization from 2000 to 2009, especially by podiatrists in private offices. J Am Coll Radiol (2012) 0.96

Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound. Ultrasound Med Biol (2007) 0.96

Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys (2011) 0.96

Stress sonography of the ulnar collateral ligament of the elbow in professional baseball pitchers: a 10-year study. Am J Sports Med (2014) 0.95

Prostate: high-frequency Doppler US imaging for cancer detection. Radiology (2002) 0.95

Reconstruction for missed or neglected Achilles tendon rupture with V-Y lengthening and flexor hallucis longus tendon transfer through one incision. Foot Ankle Int (2007) 0.95

Ultrasound-guided injections for de Quervain's tenosynovitis. Clin Orthop Relat Res (2012) 0.94

Probability of late rectal morbidity in 125I prostate brachytherapy. Int J Radiat Oncol Biol Phys (2003) 0.94

Dynamic sonographic evaluation of peroneal tendon subluxation. AJR Am J Roentgenol (2004) 0.94

NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers. J Natl Cancer Inst (2012) 0.94

Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations. Breast (2008) 0.94

Noninvasive LV pressure estimation using subharmonic emissions from microbubbles. JACC Cardiovasc Imaging (2012) 0.94

Chronic inflammatory appendiceal conditions that mimic acute appendicitis on helical CT. AJR Am J Roentgenol (2002) 0.93

Cost and radiation savings of partial substitution of ultrasound for CT in appendicitis evaluation: a national projection. AJR Am J Roentgenol (2014) 0.93

Subharmonic signal generation from contrast agents in simulated neovessels. Ultrasound Med Biol (2004) 0.93

Quality assurance peer review chart rounds in 2011: a survey of academic institutions in the United States. Int J Radiat Oncol Biol Phys (2012) 0.93

Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos. Mol Cancer Ther (2009) 0.93

Three-dimensional subharmonic ultrasound imaging in vitro and in vivo. Acad Radiol (2012) 0.93

On the merits and limitations of whole-brain radiation therapy. J Clin Oncol (2012) 0.93

Advantages of real-time spatial compound sonography of the musculoskeletal system versus conventional sonography. AJR Am J Roentgenol (2002) 0.92

Systematic review of hypofractionated radiation therapy for prostate cancer. Cancer Treat Rev (2013) 0.92

Evaluation of posterior tibial pathology: comparison of sonography and MR imaging. Skeletal Radiol (2005) 0.92

Noninvasive estimation of dynamic pressures in vitro and in vivo using the subharmonic response from microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 0.92

Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. AJR Am J Roentgenol (2013) 0.91

Common sonographic findings in the painful hip after hip arthroplasty. J Ultrasound Med (2012) 0.91

Does extended-field-of-view sonography improve interrater reliability for the detection of rotator cuff muscle atrophy? AJR Am J Roentgenol (2008) 0.91

A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys (2006) 0.91

Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma. BMC Genomics (2012) 0.91

Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: a population-based analysis. Am J Clin Oncol (2013) 0.91

Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate base. Brachytherapy (2005) 0.91

Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos. BMC Dev Biol (2010) 0.91

Color Doppler imaging evaluation of proximal vertebral artery stenosis. AJR Am J Roentgenol (2009) 0.90

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610. Radiat Oncol (2013) 0.90

Contrast-enhanced two- and three-dimensional sonography for evaluation of intra-abdominal hemorrhage. J Ultrasound Med (2002) 0.90